NOTE 1 – BUSINESS SUMMARY OF SIGNIFICANT ACCOUNTING PRINCIPLES AND GOING CONCERN
Nature of Business
First Foods Group, Inc. (the “Company” or “First Foods”) is a smaller reporting company focused on developing its specialty chocolate product line through its Holy Cacao subsidiary, participating in merchant cash advances (“MCAs”) through its 1st Foods Funding Division, and introducing new health-related brands, concepts and products through its FFGI Wholesaling Division.
Holy Cacao is a majority owned subsidiary that is dedicated to producing, packaging, distributing and selling specialty chocolate products, including specialty chocolate products infused with a hemp-based ingredient in accordance with the Company’s understanding of the Agricultural Act of 2014 (the “2014 Farm Bill”) and/or the Agriculture Improvement Act of 2018 (the “2018 Farm Bill,” and together with the 2014 Farm Bill, collectively, the “Farm Bill”), which renders the production of hemp in compliance with the provisions of the Farm Bill federally lawful. The Company has not been, is not, and has no current plans to be involved in producing, packaging, distributing or selling any product that is infused with a marijuana-based ingredient, although it intends to revisit the matter as regulations change in jurisdictions in which it operates.
The Company is also dedicated to licensing its intellectual property (“IP”), including its name, brand, and packaging, to third parties. The Company may license its IP to third parties that may produce, package, and distribute hemp-based products pursuant with the Company’s understanding of the Farm Bill. The Company may license its IP to third parties that may produce, package, and distribute marijuana-based products, but only as such licensing is legal. Holy Cacao holds four trademarks for the brands, “The Edibles Cult”, “Purely Irresistible”, “Mystere” and “Southeast Edibles”.
The Company also has a contract with TIER Merchant Advances LLC (“TIER”) to participate in the purchase of future receivables from qualified TIER merchants for the purpose of generating revenue for the Company. The Company also provides cash advances directly to merchants.
Quarterly Reporting
The accompanying unaudited condensed consolidated financial statements (“financial statements”) have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and have been consistently applied. Certain information and footnote disclosures normally included in financial statements presented in accordance with GAAP, but which are not required for interim reporting purposes, have been omitted. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary to present fairly the financial position as of March 31, 2023 and the results of operations and cash flows for the interim periods ended March 31, 2023 and 2022, have been included. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes thereto for the year ended December 31, 2022 included in the Company’s Annual Report on Form 10-K, as filed with the Securities and Exchange Commission on April 17, 2023. Operating results for the three months ended March 31, 2023 are not necessarily indicative of the results that may be expected for the full year ending December 31, 2023.
Liquidity and Going Concern
The Company’s consolidated financial statements are prepared using generally accepted accounting principles in the United States of America (“GAAP”) applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations.
In order to continue as a going concern, the Company will need, among other things, additional capital resources. As of March 31, 2023, the Company had approximately $1,367,000 in third-party short-term debt and approximately $2,600 in associated debt discount and approximately $954,000 in related-party short-term debt and $0 in associated debt discount that is due within the next twelve months. Management’s plan is to continue to increase revenue, obtain such resources for the Company by obtaining capital from management and significant shareholders sufficient to meet its operating expenses and seeking equity and/or debt financing. However, neither any members of management nor any significant shareholders are currently committed to invest funds with us and; therefore, we cannot provide any assurances that the Company will be successful in accomplishing any of its plans.
The Company does not have sufficient cash flow for the next twelve months from the date of this report. The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. These reasons raise substantial doubt about the Company’s ability to continue as a going concern.
Use of Estimates
The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.
Basis of Presentation
The Company’s consolidated financial statements are presented in accordance with generally accepted accounting principles in the United States of America (“GAAP”).
The noncontrolling interest represents the proportionate share of the proceeds received and also the income and loss pickup from the fifteen-percent sale of equity interest in our 85% owned subsidiary; Holy Cacao.
Principles of Consolidation
The consolidated financial statements represent the consolidation of the accounts of the Company and its subsidiary in conformity with GAAP. All intercompany accounts and transactions have been eliminated in consolidation.
Cash and Cash Equivalents
The Company considers all highly liquid temporary cash investments with an original maturity of twelve months or less to be cash equivalents. At March 31, 2023 and December 31, 2022, the Company had no cash equivalents.
The Company’s cash is held with financial institutions, and the account balances may exceed the Federal Deposit Insurance Corporation (FDIC) insurance limit at times. Accounts are insured by the FDIC up to $250,000 per financial institution. The Company has not experienced any losses in such accounts with these financial institutions.
Restricted Cash
As of March 31, 2023 restricted cash included $5,900, which was restricted pursuant to the requirements in the sales consultant agreement entered into November 2020.
Merchant Cash Advances
The Company participates in the merchant cash advance industry by directly advancing sums to a merchant or a merchant advance provider, TIER, who in turn advances sums to merchants or other merchant cash advance providers. Each reporting period, the Company reviews the carrying value of these advances and determines whether an impairment reserve is necessary. At March 31, 2023, the Company reserved an amount equal to 100% of the outstanding merchant cash advance balance at period end based on the potential impact of COVID 19. As of March 31, 2023 and December 31, 2022 the outstanding reserve balance was $168,078 and $163,842, respectively.
Revenue Recognition
We completed, related to our merchant cash advance business line, our assessment of the impact of Accounting Standards Codification (“ASC”) 606 and determined that we recognize revenue in accordance with ASC 860, Transfers and Servicing, which is explicitly excluded from the scope of ASC 606. We participate in the servicing of merchant cash advances that have been provided to third parties, which in accordance with ASC 860, causes us to recognize merchant cash advance (“MCA”) income. We also have product sales from our Holy Cacao division that follow ASC 606.
Product sales are measured based on consideration specified in a contract with a customer that we expect to receive in exchange for goods, net of any variable considerations (e.g. rights to return product, sales incentives, etc.). The Company recognizes revenue when it satisfies a performance obligation by transferring control of a product to a customer. These criteria are assumed to have been met upon delivery of the products requested by the customer to the customer’s carrier. The Company applied the practical expedient available under ASC 606 to disregard determining significant financing components, if the good is transferred and payment is received within one year.
When a merchant cash advance is purchased, the Company records a merchant cash advance participation receivable for the purchase price. The purchase price consists of the merchant cash advance principal plus an up-front commission that is amortized over the term of the merchant cash advance. The amount of the commission is negotiated between the Company and TIER for each contract. The standard commission is 15% of the merchant cash advance principal but can be reduced depending upon the credit worthiness of the merchant. The average commission paid by the Company since inception has been approximately 7%. If a merchant cash advance contract is signed in one period, but not paid until a subsequent period, a corresponding liability is established in the current period.
At the time the Company participates in a merchant cash advance, the Company records a deferred revenue liability, which is the total future receivable due to the Company less the principal amount of the merchant cash advance. Revenue is recognized and the deferred liability is reduced over the term of the merchant cash advance.
TIER maintains a bank account on behalf of the Company. Each day, TIER receives payment, reflected in the bank account, for each merchant cash advance TIER has purchased on behalf of the Company from various merchant cash advance providers. The Company reduces its merchant cash advance balance by the cash received, which is net of platform fees. Platform fees are a daily charge associated with the ACH service and the financial and reporting management software platform provided by TIER. The platform fees are also negotiated between the Company and TIER for each contract but are typically 4% of the daily merchant cash advance principal amount.
For each merchant cash advance entered into by the Company, TIER receives a daily payment as payments are made on the advance, for each merchant cash advance TIER has purchased on behalf of the Company from various merchant cash advance providers. The Company reduces its merchant cash advance balance by the cash received, which is net of a 2% commission to TIER.
The following table shows net sales by category for March 31, 2023 and 2022: | | | | | | | | | |
| | | | | | | | | |
| | 2023 | | | Change | | | 2022 | |
Net sales by category: | | | | | | | | | |
Chocolate products | | $ | 3,472 | | | | -76 | % | | $ | 14,457 | |
Merchant cash advances | | | 426 | | | | 22 | % | | | 348 | |
Total net sales | | $ | 3,898 | | | | -74 | % | | $ | 14,805 | |
Accounts Receivable and Allowance for Doubtful Accounts
Accounts receivable are carried at original invoice amount less an estimate made for doubtful accounts based on a review of all outstanding amounts. Management determines the allowance for doubtful accounts by regularly evaluating individual customer receivables and considering a customer’s financial condition, credit history and current economic conditions and sets up an allowance for doubtful accounts when collection is uncertain. Customers’ accounts are written off when all attempts to collect have been exhausted. The Company considers an invoice past due once the term of the invoice has passed and payment has not been received. No interest is charged on past due invoices. Recoveries of accounts receivable previously written off are recorded as income when received. As of March 31, 2023, the Company had no allowance for doubtful accounts.
Inventory
Inventory, consisting of raw materials, work in process and products available for sale, are accounted for using the first-in, first-out method, and are valued at the lower of cost or net realizable value. This valuation requires management to make judgements based on currently available information, about the likely method of disposition, such as through sales to individual customers and returns. The Company has an allowance for inventory reserves.
Inventory consisted of the following as of March 31, 2023 and December 31, 2022:
| | March 31, | | | December 31, | |
| | 2023 | | | 2022 | |
Raw Materials | | $ | 24,249 | | | $ | 24,249 | |
Work in Process | | | 11,948 | | | | 11,948 | |
Finished Goods | | | 2,036 | | | | 2,099 | |
Inventory Allowance | | | (38,190 | ) | | | (38,190 | ) |
Total | | $ | 43 | | | $ | 106 | |
Property and Equipment
Property and equipment are stated at cost, less accumulated depreciation and amortization. Expenditures for maintenance and repairs are charged to expense when incurred, while renewals and betterments that materially extend the life of an asset are capitalized. When assets are sold, retired or otherwise disposed of, the cost and accumulated depreciation are removed from the balance sheets and any resulting gain or loss is reflected in the consolidated statements of operations and stockholders’ deficit in the period realized.
Depreciation and amortization are provided using the straight-line method over the estimated useful lives of the assets, which are as follows:
Property – Leasehold improvements | | 4 years | |
Equipment | | 5 years | |
Impairment of Assets
The Company evaluates its assets for impairment whenever events or changes in circumstances indicate the carrying value of an asset or group of assets may not be recoverable. If these circumstances exist, recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset group to future undiscounted net cash flows expected to be generated by the asset group. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets.
Leases
The Company determines if an arrangement is a lease at the inception of a contract. Operating lease right-of-use (“ROU”) assets are included in right-of-use assets on the consolidated balance sheets. The current and long-term components of operating lease liabilities are included in the operating lease liabilities and operating lease liabilities – long term, respectively on the consolidated balance sheets.
Operating lease ROU assets and operating lease liabilities are recognized based on the present value of the future minimum lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company uses an incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments. Certain leases may include options to extend or terminate the lease. Lease expense for minimum lease payments is recognized on a straight-line basis over the lease term. Leases with an initial term of 12 months or less are not recorded in the consolidated balance sheet.
The company does not include the non-lease components that are associated with the lease and accounts for them outside of the lease in accordance with ASC Topic 842 Leases. The percentage of cost associated with the lease component was 100%.
Research and Development
The Company’s policy is to engage market and branding consultants to research and develop specialty chocolate products, including chocolate products infused with a hemp-based ingredient, and packaging targeted to particular states within the US. The research and development costs for the three months ended March 31, 2023 and 2022, were approximately $19,800 and $16,000, respectively. These expenses are included in general and administrative expenses on the accompanying consolidated statements of operations.
Deferred Financing Costs
The Company records origination and other expenses related to its debt obligations as deferred financing costs. These expenses are deferred and amortized over the life of the related debt instrument. In accordance with Accounting Standards Update (“ASU”) No. 2015-03, deferred finance costs, net of accumulated amortization have been included as a contra to the corresponding loans in the accompanying consolidated balance sheets as of March 31, 2023 and December 31, 2022, respectively.
Stock Based Compensation
The Company measures and recognizes compensation expense for all stock-based payments at fair value over the requisite service period. The Company uses the Black-Scholes option pricing model to determine the weighted average fair value of options and warrants. For restricted stock grants, fair value is determined as the closing price of our common stock on the date of grant. Equity-based compensation expense is recorded in administrative expenses based on the classification of the employee or vendor. The determination of fair value of stock-based payment awards on the date of grant using an option-pricing model is affected by our stock price, as well as by assumptions regarding a number of subjective variables. These variables include, but are not limited to, the expected stock price volatility over the term of the awards, and actual and projected employee stock option exercise behaviors.
Income Taxes
The Company provides for income taxes using the asset and liability approach. Deferred tax assets and liabilities are recorded based on the differences between the financial statement and tax bases of assets and liabilities and the tax rates in effect when these differences are expected to reverse. Deferred tax assets are reduced by a valuation allowance if, based on the weight of available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. As of December 31, 2022, the Company had a full valuation allowance against deferred tax assets. With the historical change in ownership, the Company is subject to certain NOL limitations under Section 382 of the Internal Revenue Code.
Per Share Data
In accordance with “ASC-260 - Earnings per Share”, the basic loss per common share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding. Diluted loss per common share is computed similar to basic loss per common share except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potential common shares had been issued and if the additional common shares were dilutive. There were no dilutive shares outstanding as of March 31, 2023 and December 31, 2022 because their effect would be antidilutive.
The Company had 5,333,775 and 5,429,775 warrants to purchase common stock outstanding at March 31, 2023 and December 31, 2022, respectively. The Company had 4,470,000 warrants to purchase Series B preferred stock outstanding at March 31, 2023 and December 31, 2022. The Company has outstanding one (1) Series A preferred share that is convertible into five (5) shares of the Company’s common stock outstanding at March 31, 2023 and December 31, 2022. Additionally, the Company has 354,999 Series B preferred shares, and 660,000 Series C preferred shares outstanding that are convertible into 1,774,995 and 660,000 shares of common stock, respectively, at March 31, 2023 and December 31, 2022, respectively. The warrants and preferred stock were not included in the Company’s weighted average number of common shares outstanding because they would be anti-dilutive.
Fair Value of Financial Instruments
Fair value estimates of financial instruments are made at a specific point in time, based on relevant information about financial markets and specific financial instruments. As these estimates are subjective in nature, involving uncertainties and matters of significant judgment, they cannot be determined with precision. Changes in assumptions can significantly affect estimated fair value. The carrying value of cash, merchant cash advances, accounts receivable, vendor deposits, prepaid expenses, accounts payable and accrued liabilities approximate their fair value because of the short-term nature of these instruments. Management is of the opinion that the Company is not exposed to significant market or credit risks arising from these financial instruments.
Advertising and Promotion
Advertising and promotion costs are expensed as incurred. Advertising and promotion costs for the three months ended March 31, 2023 and 2022, were approximately $7,000 and $15,000, respectively. These expenses are included in general and administrative expenses on the accompanying consolidated statements of operations.
Non-Controlling Interests in Condensed Consolidated Financial Statements
In June 2011, the Financial Accounting Standards Board (“FASB”) issued ASC 810-10-65-1, to clarify that a non-controlling (minority) interest in a subsidiary is an ownership interest in the entity that should be reported as equity in the consolidated financial statements. It also requires consolidated net income to include the amounts attributable to both the parent and non-controlling interest, with disclosure on the face of the consolidated income statement of the amounts attributed to the parent and to the non-controlling interest. In accordance with ASC 810-10-45-21, those losses attributable to the parent and the non-controlling interest in subsidiaries may exceed their interests in the subsidiary’s equity. The excess and any further losses attributable to the parent and the non-controlling interest shall be attributed to those interests even if that attribution results in a deficit non-controlling interest balance. During the year ended December 31, 2017, the Company entered into a subscription agreement for the sale of a ten-percent equity interest in its then wholly owned subsidiary, Holy Cacao, for $200,000 in cash proceeds, in the aggregate. During the year ended December 31, 2019, 5% equity was issued to a service provider due to the completion of Holy Cacao’s first sale of its product, as per the agreement with the service provider. The Company’s periodic reporting now includes the results of operations of Holy Cacao, with the fifteen-percent ownership reported as non-controlling interests.
The following table summarizes the results of operations for Holy Cacao for the period:
| | For The Three Months Ended | |
| | March 31, | |
| | 2023 | | | 2022 | |
Revenue | | $ | 3,472 | | | $ | 14,457 | |
Cost of Goods Sold | | | (76 | ) | | | (2,481 | ) |
Operating Expense | | | (67,366 | ) | | | (126,303 | ) |
Other Income | | | 66,000 | | | | - | |
Income (Loss) from Operations | | $ | 2,030 | | | $ | (114,327 | ) |
The Company conducts business as two operating segments, First Foods and Holy Cacao. The Company does not distinguish between the two segments and has only one reportable segment based on quantitative thresholds. The accounting policies of the segments are the same as the accounting policies of the Company as a whole. The operating results of these business segments are regularly reviewed by the Company’s chief operating decision maker.
Recent Accounting Pronouncements
From time to time, new accounting pronouncements are issued by the FASB or other standard setting bodies. Unless otherwise discussed, the Company believes that the impact of recently issued standards that are not yet effective will not have a material impact on its consolidated financial position or results of operations upon adoption.
In June 2016, the FASB issued ASU 2016-13, “Financial Instruments – Credit Losses” to improve information on credit losses for financial assets and net investment in leases that are not accounted for at fair value through net income. ASU 2016-13 replaces the current incurred loss impairment methodology with a methodology that reflects expected credit losses. In April 2019 and May 2019, the FASB issued ASU No. 2019-04, “Codification Improvements to Topic 326, Financial Instruments-Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments” and ASU No. 2019-05, “Financial Instruments-Credit Losses (Topic 326): Targeted Transition Relief” which provided additional implementation guidance on the previously issued ASU. In November 2019, the FASB issued ASU 2019-10, “Financial Instruments - Credit Loss (Topic 326), Derivatives and Hedging (Topic 815), and Leases (Topic 842),” which defers the effective date for public filers that are considered small reporting companies (“SRC”) as defined by the Securities and Exchange Commission to fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company adopted ASU 2016-13 as of January 1, 2023, there was no material impact on its consolidated financial statements.
In May 2021, the FASB issued ASU 2021-04, “Earnings Per Share (Topic 260), Debt - Modifications and Extinguishments (Subtopic 470-50), Compensation - Stock Compensation (Topic 718), and Derivatives and Hedging – Contracts in Entity’s Own Equity (Subtopic 815-40): Issuer’s Accounting for Certain Modifications or Exchanges of Freestanding Equity – Classified Written Call Options (a consensus of the FASB Emerging Issues Task Force).” The ASU addresses how an issuer should account for modifications or an exchange of freestanding written call options classified as equity that is not within the scope of another Topic. For both public and private companies, the ASU is effective for fiscal years beginning after December 15, 2021. The Company adopted ASU 2021-04 as of January 1, 2022, there was no material impact on its consolidated financial statements.
NOTE 2 – RELATED PARTY TRANSACTIONS
Employment Agreement
On March 1, 2017, Mark J. Keeley assumed the role of Chief Financial Officer (“CFO”). Pursuant to his Employment Agreement, the CFO shall receive $20,833 per month. Additionally, Mr. Keeley earns an additional $40,000 per year for his role as a Director of the Board. As of March 31, 2023 and December 31, 2022, the Company has accrued $891,667 and $829,167, respectively, in relation to the employment agreements and $28,735 and $27,828, respectively, in relation to the payroll tax liability.
Consulting Agreements
On February 27, 2017, Harold Kestenbaum assumed the role of Chairman of the Board of Directors and Interim Chief Executive Officer (“Interim CEO”). Mr. Kestenbaum earned $40,000 per year for his role as Chairman of the Board and no longer takes compensation. As of March 31, 2023, the Company has accrued a total of $40,000 of compensation for his role as Interim CEO under a previous agreement.
The Company has a consulting agreement with R and W Financial (a company owned by a director) for $5,000 a month. The agreement is for an indefinite period of time and is subject to cancellation by either party with written notice of 30 days. The outstanding balance as of March 31, 2023 and 2022 was $225,383 and $162,068, respectively.
Related Party Loans
| | | | | | | | | | | Associated equity instruments recorded as debt discount | | | | | | | |
| | | | | | | Original | | New | | Common | | | Fair Value of Common | | | | | | Fair Value of | | | | | | | |
| | | | Interest | | | Maturity | | Maturity | | Shares | | | Shares | | | Warrants | | | Warrants | | | March 31, | | | December 31, | |
| | | | Rate | | | Date | | Date** | | issued | | | issued | | | issued | | | issued | | | 2023 | | | 2022 | |
| 1 | | | | 12%* | | | 4/17/22 | | 10/31/23 | | | | | | | | | | | | | | | | | | $ | 100,000 | | | $ | 100,000 | |
| 2 | | | | 0%* | | | 4/24/22 | | 7/15/23 | | | | | | | | | | | | | | | | | | | 179,813 | | | | 179,813 | |
| 3 | | | | 12%* | | | 4/16/22 | | 7/31/23 | | | | | | | | | | | | | | | | | | | 150,000 | | | | 150,000 | |
| 4 | | | | 0%* | | | 9/15/22 | | 7/15/23 | | | | | | | | | | | | | | | | | | | 500 | | | | 500 | |
| 5 | | | | 0%* | | | 5/30/22 | | 12/31/23 | | | | | | | | | | | | | | | | | | | 516,600 | | | | 433,000 | |
| 6 | | | | 0%* | | | 8/24/22 | | 7/15/23 | | | | | | | | | | | | | | | | | | | 7,000 | | | | 7,000 | |
Total | | | | | | | | | | | | | | | | | | | | | | | $ | 953,913 | | | $ | 870,313 | |
* - unsecured note
** - During the three month end periods ended March 31, 2023 and 2022, the company extended the terms of the notes identified above, the extension of the term was accounted for as a modification to the original note. The company capitalized new costs of $0 and $0, for the period ended March 31, 2023 and 2022, respectively, as a result of the modifications.
During the three months ended March 31, 2023 and 2022, the Company recorded $0 and $15,512 of interest expense related to the amortization of debt discount and $5,918 and $5,918 of regular interest, respectively.
As of March 31, 2023 and December 31, 2022, accrued interest was $98,067 and $74,067, respectively.
Related Party Payables
As of March 31, 2023 and December 31, 2022, the Company owed a Director $261,678 and $182,488, respectively, for expenses incurred on behalf of the Company.
Director Agreements
The Company annually revisits the board of director agreements, which include quarterly compensation of $10,000 per director for the fiscal year. Three of the five board members currently are compensated under these terms, while the other two board members remain unpaid. As of March 31, 2023 and December 31, 2022, the Company has accrued $530,000 and $500,000, respectively, in relation to the director agreements and is included in Accounts payable and accrued liabilities - related parties on the consolidated balance sheet.
On July 7, 2020, our Board of Directors appointed Michael Kaplan to the Board of Directors who currently remains as an uncompensated board member (see note 6 for details). If terminated with cause by the Company, the consultant shall not thereafter be entitled to any form of compensation, the unvested warrants shall terminate, and he shall be paid a buyout fee in the amount of 250,000 fully vested warrants. If terminated without cause by the Company, all unvested warrants shall be accelerated and vest in one-half the time it was previously scheduled to vest.
NOTE 3 – PROPERTY AND EQUIPMENT
Property and equipment, net consists of the following:
| | March 31, 2023 | | | December 31, 2022 | |
Leasehold improvements | | $ | 40,000 | | | $ | 40,000 | |
Equipment | | | 240,392 | | | | 240,392 | |
Less: Accumulated depreciation and amortization | | | (141,289 | ) | | | (141,289 | ) |
Less: Impairment | | | (139,103 | ) | | | (139,103 | ) |
Total | | $ | - | | | $ | - | |
NOTE 4 – ACCOUNTS PAYABLE AND ACCRUED LIABILITIES
Accounts payable and accrued liabilities consist of the following:
| | March 31, | | | December 31, | |
| | 2023 | | | 2022 | |
Accounts Payable | | $ | 368,647 | | | $ | 322,547 | |
Interest | | | 436,107 | | | | 391,160 | |
Other | | | 38,040 | | | | 47,094 | |
Total third party payables | | | 842,794 | | | | 760,801 | |
Related party payables, officers and director fees | | | 1,977,463 | | | | 1,869,131 | |
Total payables | | $ | 2,820,257 | | | $ | 2,629,932 | |
NOTE 5 – LOANS AND LONG-TERM LOANS
| | | | Interest Rate | | | Original Maturity Date | | New Maturity Date **** | | Common Shares issued | | | Fair Value of Common Shares issued ($) | | | Warrants issued | | | Fair Value of Warrants issued ($) | | | March 31, 2023 | | | December 31, 2022 | |
| 1 | | | | 12%* | | | 4/16/2022 | | 12/31/2023 | | | | | | | | | | | | | | $ | 50,000 | | | $ | 50,000 | |
| 2 | | | | 12%* | | | 4/22/2022 | | 12/31/2023 | | | | | | | | | | | | | | | | | | | 18,000 | | | | 18,000 | |
| 3 | | | | 12%* | | | 6/30/2022 | | 12/31/2023 | | | | | | | | | | | | | | | | | | | 250,000 | | | | 250,000 | |
During the three months ended March 31, 2023 | | | - | | | | - | | | | - | | | | - | | | | | | | | | |
During the three months ended March 31, 2022 | | | - | | | | - | | | | 125,000 | | | | 28,088 | | | | | | | | | |
| 4 | | | | 12%* | | | 4/16/2022 | | 12/31/2023 | | | | | | | | | | | | | | | | | | | 410,000 | | | | 410,000 | |
| 5 | | | | 12%* | | | 4/16/2022 | | 12/31/2023 | | | | | | | | | | | | | | | | | | | 140,000 | | | | 140,000 | |
| 6 | | | | 12%* | | | 4/30/2022 | | 12/31/2023 | | | | | | | | | | | | | | | | | | | 200,000 | | | | 200,000 | |
| 7 | | | | 12%* | | | 7/31/2022 | | 12/31/2023 | | | | | | | | | | | | | | | | | | | 60,000 | | | | 60,000 | |
During the three months ended March 31, 2023 | | | - | | | | - | | | | - | | | | - | | | | | | | | | |
During the three months ended March 31, 2022 | | | 60,000 | | | | 12,600 | | | | - | | | | - | | | | | | | | | |
| 8 | | | | 12%* | | | 7/29/2022 | | 12/31/2023 | | | | | | | | | | | | | | | | | | | 96,000 | | | | 96,000 | |
| 9 | | | | 3.75% ** | | | 6/25/2050 | | | | | | | | | | | | | | | | | | | | | 150,000 | | | | 150,000 | |
| 11 | | | | 0%* | | | 9/19/2022 | | 7/1/2023 | | | | | | | | | | | | | | | | | | | 16,500 | | | | 16,500 | |
| 12 | | | | 0%* | | | 4/16/2022 | | 12/31/2023 | | | | | | | | | | | | | | | | | | | 50,000 | | | | 50,000 | |
| 13 | | | | 0% *** | | | 4/16/2022 | | 7/15/2023 | | | | | | | | | | | | | | | | | | | 30,000 | | | | 30,000 | |
| 14 | | | | 0%* | | | 4/16/2022 | | 12/31/2023 | | | | | | | | | | | | | | | | | | | 13,000 | | | | 13,000 | |
| 15 | | | | 0% *** | | | 5/30/2022 | | 12/31/2023 | | | | | | | | | | | | | | | | | | | 30,000 | | | | 30,000 | |
| 16 | | | | 0% | | | 11/30/2022 | | 12/31/2023 | | | | | | | | | | | | | | | | | | | 5,950 | | | | 5,950 | |
| Unamortized debt discount | | | | | | | | | | | | | | | | | | | | | (2,625) | | | | (4,545) | |
| Total | | | | | | | | | | | | | | | | | | | | | 1,516,825 | | | | 1,518,505 | |
| Less: short term loans, net | | | | | | | | | | | | | | | | | | | | | 1,366,825 | | | | 1,368,505 | |
| Total long-term loans, net | | | | | | | | | | | | | | | | | | | | $ | 150,000 | | | $ | 150,000 | |
* - unsecured note
** - secured note and collateralized by all tangible and intangible personal property
*** - unsecured note and guaranteed by a Director of the Company
**** - During the three month end periods ended March 31, 2023 and 2022, the company extended the terms of the notes identified above, the extension of the term was accounted for as a modification to the original note. The company capitalized new costs of $0 and $40,688, for the period ended March 31, 2023 and 2022, respectively, as a result of the modifications.
During the three months ended March 31, 2023 and 2022, the Company recorded $1,920 and $47,344 of interest expense related to the amortization of debt discount and $37,604 and $41,856 of regular interest, respectively. As of March 31, 2023 and December 31, 2022, accrued interest was $322,644 and $285,733, respectively.
As of March 31, 2023 and December 31, 2022, accrued interest associated with the economic injury disaster loan was $15,396 and $13,278, respectively.
NOTE 6 – STOCKHOLDERS’ DEFICIT
Warrant Activity
Common Stock Warrants
On July 7, 2020, our Board of Directors appointed Michael Kaplan to the Board of Directors. In connection with the agreement one million (1,000,000) warrants were issued. The warrants are valued at $177,200 based on the Black Scholes Model. For the three months ended March 31, 2023 and 2022, the Company recorded $0 and $0 as compensation expense related to the warrants, respectively.
Prior to Mr. Kaplan’s appointment to the Board of Directors, on July 7, 2020 the Company entered into a Consulting Agreement with Mr. Kaplan to award him, as full compensation for two (2) years of service, warrants to purchase two million (2,000,000) shares of common stock at an exercise price of $0.18 per share, which was the closing price of our common stock on such date. The warrants are valued at $354,400 based on the Black Scholes Model. Due to the fact that management has assessed the probability of certain milestones being met as probable, the warrants are being straight-lined over the term of services and accelerated whenever a milestone is met. The probability of the remaining milestones being met is reviewed by management every quarter. For the three months ended March 31, 2023 and 2022, the Company recorded $0 and $41,508 as compensation expense related to the warrants. The warrants shall vest upon the occurrence to the Company of the following milestone events through the efforts of the consultant:
No. of Warrants | | Milestone |
100,000 | | Acceptance by the Company of a full go-to market strategy for the Company's products. This milestone has been achieved. |
100,000 | | Acceptance by the Company of a social marketing platform and PR strategy and onboarding of such. |
300,000/500,000 | | 300,000 for each multi outlet (“MULO”) retailer that is onboarded - regardless of store count carrying the product; and 500,000, if the onboarded MULO is a national chain. |
300,000 | | Deliverance of full due diligence package for each potential acquisition for which the Company requests the consultant perform due diligence |
500,000 | | Upon the closing of any acquisition which the consultant brought to the Company and provided due diligence. |
500,000 | | Additional compensation in board seat agreement. |
On August 4, 2020, the Company signed an Employment Agreement for a term of three years with an annual base salary of eighty four thousand dollars ($84,000). As part of the agreement the Company will issue a warrant to the employee to purchase 300,000 shares a year, for a total of 900,000 shares of the Company’s common stock. The warrants have a term of three (3) years from date of issue and an exercise price equal to the closing market price of the Company’s common stock on August 4, of the corresponding year. The warrants issued on August 4, 2020 and 2021, are valued at $97,470 and $46,050, respectively, based on the Black Scholes Model. The warrants will be subject to a 12-month period whereby the warrants will vest in equal monthly increments for each year of the employment period. Once per quarter, the employee may waive the right to receive 25,000 warrants and receive in exchange for $5,000 worth of shares of the Company’s common stock. In the event the employee’s employment is terminated by the Company without cause, the employee shall be entitled to receive severance in an amount equal to the lesser of three month’s salary or the amount of salary otherwise payable until the termination date. The employee additionally shall be entitled to retain all warrants scheduled to vest within the following six months. For the three months ended March 31, 2023 and 2022, the Company recorded $5,607 and $30,153 as compensation expense related to the warrants, respectively.
On March 21, 2022, the Company extended the maturity date on one of its promissory notes (see Note 5). In association with this extension the company granted warrants for the right to purchase 125,000 shares of common stock at an exercise price of $0.24 a share. The warrants are valued at $28,088 based on the Black Scholes Model, are fully vested as of the issue date and have an exercise term of three (3) years. The Company recorded a debt discount and will amortize it over the life of the loan.
The Company utilized the Black-Scholes option-pricing model to estimate fair value, utilizing the following assumptions for the respective period:
| | 2023 | | | 2022 | |
Risk-free interest rate | | | - | % | | 0.22-3.16 | % |
Expected term of options, in years | | | - | % | | | 3 | |
Expected annual volatility | | | - | % | | 211.0-235.0 | % |
Expected dividend yield | | - | % | | - | % |
Determined grant date fair value per option | | $ | - | | | $ | 0.08-0.22 | |
A summary of the Company’s warrants to purchase common stock activity is as follows:
| | Number of Warrants (in common shares) | | | Weighted Average Exercise Price | |
Outstanding, December 31, 2021 | | | 5,704,775 | | | | 0.22 | |
Granted | | | 785,000 | | | | 0.14 | |
Exercised | | | - | | | | - | |
Forfeited or cancelled | | | (1,060,000 | ) | | | 0.31 | |
Outstanding, December 31, 2022 | | | 5,429,775 | | | $ | 0.19 | |
Granted | | | - | | | | - | |
Exercised | | | - | | | | - | |
Forfeited or cancelled | | | (96,000 | ) | | | 0.22 | |
Outstanding, March 31, 2023 | | | 5,333,775 | | | | 0.19 | |
As of March 31, 2023, 3,333,775 warrants for common stock were exercisable and the intrinsic value of these warrants was $0, the weighted average remaining contractual life for warrants outstanding was 1.3 years and the remaining expense is $7,850 over the remaining amortization period which is six months.
As of March 31, 2022, 4,069,775 warrants for common stock were exercisable and the intrinsic value of these warrants was $184,014, the weighted average remaining contractual life for warrants outstanding was 1.92 years and the remaining expense is $61,095 over the remaining amortization period which is four months.
Preferred Stock Warrants
A summary of the Company’s warrants to purchase Series B Preferred Stock activity is as follows:
| | Number of Warrants (in Series B Preferred Stock) | | | Weighted Average Exercise Price | |
Outstanding, December 31, 2021 | | | 4,470,000 | | | $ | 0.68 | |
Granted | | | - | | | | - | |
Exercised | | | - | | | | - | |
Forfeited or cancelled | | | - | | | | - | |
Outstanding, December 31, 2022 | | | 4,470,000 | | | $ | 0.68 | |
Granted | | | - | | | | - | |
Exercised | | | - | | | | - | |
Forfeited or cancelled | | | - | | | | - | |
Outstanding, March 31, 2023 | | | 4,470,000 | | | $ | 0.68 | |
As of March 31, 2023, 4,470,000 warrants for Series B preferred stock were exercisable and the intrinsic value of these warrants was $0, the weighted average remaining contractual life for warrants outstanding was 5.12 years.
As of March 31, 2022, 4,470,000 warrants for Series B preferred stock were exercisable and the intrinsic value of these warrants was $2,674,350, the weighted average remaining contractual life for warrants outstanding was 6.12 years.
NOTE 7 – LEASES
On June 23, 2020, the Company entered into an operating lease agreement with a term of 4 years, and an option to extend for three years, comprising of office and warehouse space. This option is included in the lease term when it is reasonably certain that the option will be exercised and failure to exercise such option will result in economic penalty and as such the option to extend for the three-year term is not included in the below calculation.
For each of the three months ended March 31, 2023 and 2022, the Company incurred lease expense for its operating leases of $21,911, which was included in general and administrative expenses on the accompanying unaudited condensed consolidated statements of operations.
During the year ended December 31, 2022, the Company recognized an impairment of $107,233 in relation to the Company’s right-of-use assets related to the change in business strategy. The corresponding lease liabilities will remain until the Company satisfies its lease obligations.
The Company’s weighted-average remaining lease term relating to its operating leases is 1.08 years, with a weighted-average discount rate of 12.00%.
The Company had cash payments for operating leases of $21,806 for each of the three months ended March 31, 2023 and 2022.
The following table presents information about the amount, timing and uncertainty of cash flows arising from the Company’s operating leases as of March 31, 2023.
Maturity of Lease Liability | | | |
2023 | | | 67,555 | |
2024 | | | 30,120 | |
Total undiscounted operating lease payments | | | 97,675 | |
Less: Imputed interest | | | 6,521 | |
Present value of operating lease liabilities | | $ | 91,154 | |
NOTE 8 – COMMITMENTS
On January 14, 2021, the Company entered into an agreement with a sales consultant to further the business purpose of the Company. In consideration for the services provided by the consultant, the consultant will receive a commission of the gross sales (net of returns) that were directly generated by the consultant to new customers. This agreement shall continue for sixty months from the date of the agreement and will automatically extend for additional successive sixty month terms unless written notice is delivered at least thirty days prior to the end of the current term.
On January 4, 2022, the Company entered into a grant agreement with a sales consultant. As compensation for the services, the Company will issue up to 2,380,952 shares of restricted common stock to the sales consultant in monthly installments over the twenty (24) month term of the agreement. The number of shares to be issued by the Company to the sales consultant on a monthly basis will be determined by the amount of net sales of products generated by the sales consultant at the end of each month multiplied by a fixed percentage of 5% divided by the last closing market price of the shares as of the effective date. Additionally, if the sales consultant makes sales using salespeople who are not under contract with the Company, the Company will pay the consultant a cash commission at the end of each month equal to 5% of net sales over the term. During the three months ended March 31, 2023 and 2022, no shares have been issued, respectively.
On March 2, 2022, the Company entered into two agreements with two consultants to further the business purpose of the Company. In consideration for the services provided by the consultants, the consultants will receive a 10% commission of the gross sales (net of returns) that were directly generated by the consultants to new customers. This agreement shall continue for sixty months from the date of the agreement and will automatically extend for additional successive sixty-month terms unless written notice is delivered at least thirty days prior to the end of the current term.
During the three months ended March 31, 2023 and 2022, no shares have been issued, respectively.
On March 23, 2022, the Company entered into a grant agreement with a sales consultant. As compensation for the services, the Company will issue up to 2,083,333 shares of restricted common stock to the sales consultant in monthly installments over the twenty (24) month term of the agreement. The number of shares to be issued by the Company to the sales consultant on a monthly basis will be determined by the amount of net sales of products generated by the sales consultant at the end of each month multiplied by a fixed percentage of 5% divided by the last closing market price of the shares as of the effective date. During the three months ended March 31, 2023 and 2022, no shares have been issued, respectively.
On April 11, 2022, the Company entered into a memo of understanding with a marketing consultant, who is a National Football League (NFL) celebrity. As compensation for the services, the Company agrees to split the net profit on a 50 / 50 basis derived from the sales of the Company’s products that will be branded under the consultant’s name and result from the marketing consultant’s efforts. The marketing consultant will be paid on a quarterly basis over the two (2) year term.
The Company did not incur any commission costs during the three months ended March 31, 2023 and 2022, respectively. As of March 31, 2023 and 2022, there were no accrued commissions outstanding.
NOTE 9 – CONCENTRATION RISKS
The Company recognizes the concentration of its merchant cash advances, which could inherently create a potential risk to future working capital in the event that the Company is not able to collect all, or a majority, of the outstanding merchant cash advances. The Company actively mitigates its portfolio concentration risk by monitoring its merchant cash advance provider’s ability to participate in merchant cash advances from alternative providers and spreading merchant cash advance participation across various merchants.
As of March 31, 2023 and December 31, 2022, the Company's concentrations for receivables from merchant cash advances as well as income from merchant cash advances were not significant to warrant concentration risk.
The Company earned $14,949 of MCA income from one merchant, representing 57% of the Company’s MCA income for the three months ended March 31, 2022.
For the three months ended March 31, 2023, the Company had no purchase concentrations.
For the three months ended March 31, 2022, the Company had purchase concentrations of 54% and 27% from two vendors.
NOTE 10 – SUBSEQUENT EVENTS
As of the date of this filing, the Company did not have any subsequent events to report.